.gif)
Bausch & Lomb launch Obagi’s blockbuster products like Thermage, Fraxel, Vaser & Clear + Brilliant and few more offerings in the pipeline. This strategic move of expanding in the premium skincare segment, would further strengthen Bausch & Lomb’s position in the INR 285 - 290 billion beauty care market, growing at a rate 15 to 20 per cent per annum (As per FICCI Wellness Report 2013).
Obagi is the number one physician recommended skincare brand in US. The product portfolio includes a wide range of formulations designed to address skin concerns like premature skin aging, skin damage, hyperpigmentation, acne and sun damage. In the first phase of its entry in the skincare segment, Bausch & Lomb has launched Hydrate Moisturizer, Professional-C Serums and ELASTIderm, from the ‘targeted solutions’ and ‘essential products’ portfolio for home care. It has also launched Obagi Blue peel which is into the professional care range.
In addition to the skincare products, Bausch & Lomb also plans to launch Obagi’s highly-targeted skincare procedures, during the next phase of expansion. The products will be available through India’s leading physicians, primarily dermatologists, plastic surgeons, and other skin care and medical professionals.
Subscribe to PharmaTutor News Alerts by Email >>
